FDA 503A Category 2 (April 2026) On April 15, 2026, the FDA published a 503A bulks list update
Your body needs time to adjust, and your skin needs time to tighten as you slim down
The agency is aware that some semaglutide products sold by compounders may be the salt forms
Serum uric acid level is associated with cardiac hypertrophy in renal transplant recipients
what are the top selling glp 1 medications in the u s This report provides a comprehensive analysis of the top-selling GLP-1 (glucagon-like peptide-1) medications in the United States, focusing on market performance, consumer preferences, and future trends as of 2025
In these two Phase 3 studies (n=3,680 total), patients are randomized to placebo or oral semaglutide in a 1:1 ratio and assessed using the CDR-SB at 2 years, with follow-up of up to 3 years